Satoru Taguchi, Taketo Kawai, Yoshiki Ambe, Kenjiro Kishitani, Michio Noda, Tomoyuki Kaneko, Jimpei Miyakawa, Yu Nakamura, Hayato Hoshina, Daisuke Obinata, et al. Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis. International journal of urology : official journal of the Japanese Urological Association. 2024
Daisuke Obinata, Makoto Hara, Sho Hashimoto, Ken Nakahara, Tsuyoshi Yoshizawa, Junichi Mochida, Kenya Yamaguchi, Satoru Takahashi. Association Between Frailty and Pelvic Organ Prolapse in Elderly Women: A Retrospective Study. International urogynecology journal. 2024. 35. 9. 1889-1898
Tsuyoshi Yoshizawa, Yoko Nakanishi, Daisuke Obinata, Kenya Yamaguchi, Shinobu Masuda, Satoru Takahashi. AKR1C3-negative high-risk metastatic castration-sensitive prostate cancer has long-term response to first-line treatment with abiraterone: Four case reports. Urology case reports. 2024. 54. 102727-102727
CT Volumetry of Estimated Residual kindney for prediction of postoperative chronic kindney disease in patients with renal cell carcinoma
(Annual Meeting of the American Urological Association 2019 2019)
CT volumetry of estimated residual kidney for prediction of postoperative chronic kidney disease in patients with renal cell carcinoma
(ISTUA (International Symposium of Taiwan Urological Association) 2018)
Predictive factor of efficacy by Enzalutamide.
(The International Section of Taiwan Urological Association Conference 2017 2017)
Predictive factor of effect by Enzalutamide.
(第105回日本泌尿器科学会総会 2017)
Failure of prostate specific antigen decrease by fifty percent from baseline following 5 alpha reductase inhibitor is associated with high positive rate of prostate cancer at subsequent biopsy in real-life setting.
(Annual meeting of the American Urological Association. 2015)
